Objective Microprolactinomas are currently treated with dopamine agonists. Outcome
information on microprolactinoma patients treated by surgery is limited. This study reports …

Cases with pituitary adenoma comprise 10–25% of intracranial neoplasm, being the third
most common intracranial tumor, most of the adenomas are considered to be benign. About …

Pituitary adenohypophyseal tumors are considered as benign and termed “adenomas”.
However, many tumors are invasive and a proportion of these exhibit an “aggressive …

Abstract Purpose Pituitary neuroendocrine tumors (PitNETs) are frequent intracranial
neoplasms that present heterogenic characteristics. Little is known about the immune cell …

Context A sex difference in the progression of prolactin (PRL) tumors has been disputed for
years. Objective To compare tumor characteristics and postoperative clinical course …

Pituitary tumours, the most frequent intracranial tumour, are historically considered benign.
However, various pieces of clinical evidence and recent advances in pathological and …

The behaviour of lactotroph tumours varies between benign tumours, those cured by
treatment, and that of aggressive tumours, and carcinomas with metastasis. Identification of …

Secreting pituitary adenomas that cause acromegaly and Cushing's disease, as well as
prolactinomas and thyrotroph adenomas, are uncommon, usually benign, slow-growing …

Invasive pituitary adenomas and pituitary carcinomas are clinically indistinguishable until
identification of metastases. Optimal management and survival outcomes for both are not …

Purpose Renewed interest in transsphenoidal surgery (TSS) as a therapeutic option for
prolactinomas has emerged. Methods Based on contemporary literature and own …